Common side effects of GLP-1s are gastrointestinal issues, including nausea, vomiting, diarrhea, dehydration, and constipation
Fink D, Weissschuh N, Reuther J, Wohlleben W, Engels A: Two transcriptional regulators GlnR and GlnRII are involved in regulation of nitrogen metabolism in Streptomyces coelicolor A3(2)
It has been studied for its role in: Collagen and extracellular matrix signaling Wound healing and tissue remodeling Angiogenesis modulation Anti-inflammatory signaling balance Skin regeneration and dermal remodeling Because of these associations, it is frequently grouped with other healing peptides such as BPC-157 and TB-500
Heymsfield, S.B
It outlines exactly where to inject, in what order
No final FDA action has occurred as of early August 2026, so the timeline for any Category 1 placement remains uncertain and depends on internal agency review, potential public comment, and broader peptide policy under the current administration